| [report on the etiology of virus diseases. 1st quarter 1968. 3]. | | 1968 | 4314370 |
| [serological studies on the incidence of complement-fixing antibodies against cytomegalovirus in westberlin]. | | 1970 | 4318515 |
| [results of virological diagnosis in 19 institutes. annual report 1970. 12]. | | 1972 | 4402408 |
| kaposi's sarcoma: a reevaluation. | kaposi's sarcoma (ks) is a multicentric neoplasia of microvascular origin arising during development of immunodeficiency in human immunodeficiency virus (hiv)-infected individuals. more than 130 patients with hiv-associated ks (98% male homosexuals; median age, 35 years) have been diagnosed at the department of dermatology, university medical center steglitz, berlin, during the years 1982-1992. mucocutaneous and visceral involvement was a common finding in patients with hiv-associated ks, increa ... | 1995 | 7541146 |
| clinical experience with certican (everolimus) in de novo heart transplant patients at the deutsches herzzentrum berlin. | immunosuppressant agents have greatly increased graft and overall survival in heart transplant patients, but some of these agents (e.g., calcineurin inhibitors [cni] and corticosteroids) can also induce adverse events that may contribute to cardiac allograft vasculopathy (cav) (e.g., nephrotoxicity and cytomegalovirus infection). the current trend is therefore toward cni- and steroid-sparing regimes. this study reports on the initial clinical experience with certican (everolimus), a novel prolif ... | 2005 | 15774323 |
| [antibodies to cytomegaloviruses in blood donors]. | the use of seronegative blood products is important to prevent transfusion-associated cytomegalovirus infection in immunocompromised patients. we have screened 3,458 normal blood donors for cmv-igg-antibodies with an elisa to receive a panel of seronegative donors and to determine the antibody prevalence. 1,948 donors were seropositive. female donors had higher antibody prevalence than males in each age range tested. | 1989 | 2475395 |